High intensity continuous renal replacement therapy does not improve mortality in critically ill patients

Abstract

In critically ill patients with acute kidney injury, high intensity continuous renal replacement therapy (CRRT) (effluent flow rate >25mL/kg/h) shows no benefit on 90-day mortality and is associated with more hypophosphataemia.